(BCHMF)

$74.45 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing...

Industry: Chemicals
Sector: Basic Materials
Phone: 41 58 595 2021
Fax: 41 58 595 2043
Address:
Hauptstrasse 144, Bubendorf, Switzerland
Fingerlickengood
Fingerlickengood Apr. 7 at 2:30 PM
$CDXS So what do we know as fact right now: (1) Codexis is involved in with $MRK on the manufacturing of enlicitide (M-0616) through a biocatalytic process to produce trans-3-hydroxy-l-proline, a critical intermediate for synthesizing the oral PCSK9 inhibitor enlicitide decanoate (MK-0616), developed by Merck. (2) Codexis and $BCHMF are involved with $ALNY through the manufacturing of Vutrisiran which is currently going through an FDA fast track for the treatment of patients with transthyretin-mediated amyloidosis with cardiomyopathy/ATTR-CM. That right there ALONE makes this worth $ $3.50+. MANY additional partnerships in the works!
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 6 at 5:34 PM
$CDXS $BCHMF https://www.bachem.com/knowledge-center/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 6 at 5:14 PM
$BCHMF $CDXS There you go!
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 2 at 3:52 PM
$CDXS $BCHMF $ARWR https://fluidmgmt.ak-bio.com/newsroom/asahi-kasei-bioprocess-and-axolabs-announce-strategic-partnership-to-accelerate-oligonucleotide-therapeutics-development/
2 · Reply
Fingerlickengood
Fingerlickengood Mar. 26 at 3:50 PM
$CDXS $BCHMF https://www.biospace.com/fda/fdas-manufacturing-designation-could-derisk-mid-development-manufacturing-changes
1 · Reply
Fingerlickengood
Fingerlickengood Mar. 17 at 11:29 PM
$CDXS $BCHMF 17 March 2026 Bachem Reports Strong Sales Growth And Sustained High Profitability: "Commercial production will be ramped up gradually in 2026 while the second construction phase is completed. The successful ramp-up of commercial production in Building K is a key prerequisite for achieving the sales target in 2026." https://www.bachem.com/knowledge-center/bachem-reports-strong-sales-growth-and-sustained-high-profitability/ Can you say, "vutrisiran aka Amvuttra"
0 · Reply
Fingerlickengood
Fingerlickengood Mar. 14 at 8:31 PM
$CDXS $BCHMF https://www.cbsnews.com/brandstudio/codexis/
0 · Reply
Fingerlickengood
Fingerlickengood Mar. 11 at 10:14 PM
$CDXS $BCHMF Bachem earnings tomorrow...could there be a partnership annoucement coming? Why did they delay their earning announcement again! Phenominal!
0 · Reply
Fingerlickengood
Fingerlickengood Jan. 22 at 7:25 PM
$CDXS + $BCHMF + $LLYX.X https://informaconnect.com/asia-tides/agenda/2/#oligonucleotide-track_development-and-manufacture-of-oligonucleotides-via-enzymatic-ligation_3-45pm
4 · Reply
Fingerlickengood
Fingerlickengood Jan. 8 at 8:16 PM
$CDXS Something official with $BCHMF will be announced later this year in 2026! https://www.bachem.com/webinar/generic-api/efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
3 · Reply
Latest News on BCHMF
No data available.
Fingerlickengood
Fingerlickengood Apr. 7 at 2:30 PM
$CDXS So what do we know as fact right now: (1) Codexis is involved in with $MRK on the manufacturing of enlicitide (M-0616) through a biocatalytic process to produce trans-3-hydroxy-l-proline, a critical intermediate for synthesizing the oral PCSK9 inhibitor enlicitide decanoate (MK-0616), developed by Merck. (2) Codexis and $BCHMF are involved with $ALNY through the manufacturing of Vutrisiran which is currently going through an FDA fast track for the treatment of patients with transthyretin-mediated amyloidosis with cardiomyopathy/ATTR-CM. That right there ALONE makes this worth $ $3.50+. MANY additional partnerships in the works!
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 6 at 5:34 PM
$CDXS $BCHMF https://www.bachem.com/knowledge-center/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 6 at 5:14 PM
$BCHMF $CDXS There you go!
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 2 at 3:52 PM
$CDXS $BCHMF $ARWR https://fluidmgmt.ak-bio.com/newsroom/asahi-kasei-bioprocess-and-axolabs-announce-strategic-partnership-to-accelerate-oligonucleotide-therapeutics-development/
2 · Reply
Fingerlickengood
Fingerlickengood Mar. 26 at 3:50 PM
$CDXS $BCHMF https://www.biospace.com/fda/fdas-manufacturing-designation-could-derisk-mid-development-manufacturing-changes
1 · Reply
Fingerlickengood
Fingerlickengood Mar. 17 at 11:29 PM
$CDXS $BCHMF 17 March 2026 Bachem Reports Strong Sales Growth And Sustained High Profitability: "Commercial production will be ramped up gradually in 2026 while the second construction phase is completed. The successful ramp-up of commercial production in Building K is a key prerequisite for achieving the sales target in 2026." https://www.bachem.com/knowledge-center/bachem-reports-strong-sales-growth-and-sustained-high-profitability/ Can you say, "vutrisiran aka Amvuttra"
0 · Reply
Fingerlickengood
Fingerlickengood Mar. 14 at 8:31 PM
$CDXS $BCHMF https://www.cbsnews.com/brandstudio/codexis/
0 · Reply
Fingerlickengood
Fingerlickengood Mar. 11 at 10:14 PM
$CDXS $BCHMF Bachem earnings tomorrow...could there be a partnership annoucement coming? Why did they delay their earning announcement again! Phenominal!
0 · Reply
Fingerlickengood
Fingerlickengood Jan. 22 at 7:25 PM
$CDXS + $BCHMF + $LLYX.X https://informaconnect.com/asia-tides/agenda/2/#oligonucleotide-track_development-and-manufacture-of-oligonucleotides-via-enzymatic-ligation_3-45pm
4 · Reply
Fingerlickengood
Fingerlickengood Jan. 8 at 8:16 PM
$CDXS Something official with $BCHMF will be announced later this year in 2026! https://www.bachem.com/webinar/generic-api/efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
3 · Reply
Fingerlickengood
Fingerlickengood Jan. 6 at 3:57 PM
$CDXS $MRK $BCHMF $NVS https://themedicinemaker.com/issues/2026/articles/january/building-the-future-of-rna-manufacturing/
0 · Reply
Fingerlickengood
Fingerlickengood Dec. 19 at 11:35 PM
$CDXS "ECO Synthesis® Manufacturing Platform, a fully aqueous system that allows for massive batch sizes, feasibly scaling up to 500 kgs. $MRK $BCHMF https://www.pharmtech.com/view/how-codexis-is-transforming-rna-manufacturing"
1 · Reply
Fingerlickengood
Fingerlickengood Dec. 17 at 3:23 PM
$CDXS $BCHMF $MRK https://www.linkedin.com/posts/bachem_oligonucleotides-enzymaticligation-liquidphasesynthesis-activity-7406943770132316161-M1X1?utm_source=share&utm_medium=member_desktop&rcm=ACoAADo5XWUBEUezftCWnQa45t4uolwmtIDyz8U
0 · Reply
Fingerlickengood
Fingerlickengood Nov. 7 at 12:18 PM
$CDXS 99.9% confident soon to announce GMP partnersip with $BCHMF based on this linkedin posting. //www.linkedin.com/posts/bachem_in-our-recent-webinar-we-unpacked-the-potential-activity-7392450432830324736-j3LA?utm_source=share&utm_medium=member_desktop&rcm=ACoAADo5XWUBEUezftCWnQa45t4uolwmtIDyz8U
1 · Reply
Fingerlickengood
Fingerlickengood Oct. 28 at 6:29 PM
$CDXS $BCHMF “three emerging platforms (gene & cell therapy, radioligand therapy and xRNA) are being prioritized for continued investment into new R&D capabilities and manufacturing scale.”
0 · Reply
Fingerlickengood
Fingerlickengood Oct. 28 at 5:03 PM
$CDXS Didnt realize $NVS has a manufacturing facility in Bubendorf, Switzerland...same place $BCHMF "is expected with regard to the previously communicated development plan for Building K. Bachem continues to expect that production of the first GMP batches can begin in 2025. While the commercial production in the inspected part will be ramped up in 2026, construction work in the remaining part of the building will continue." https://www.biospace.com/press-releases/bachem-announces-progress-in-building-k-start-up-and-expansion-of-its-site-in-vista-ca
2 · Reply
Fingerlickengood
Fingerlickengood Oct. 7 at 4:08 AM
$CDXS $BCHMF "ST Pharm announced said it has signed two new supply contracts worth a combined $18.25 million (24.9 billion won) with two U.S.-based global biotech companies for oligonucleotide active pharmaceutical ingredients (APIs). The deals include a $16.56 million agreement for a commercial cardiovascular treatment scheduled for first delivery in May 2026, and a $1.69 million contract for a new clinical-stage metabolic disease treatment, with delivery set for December 2025." https://www.koreabiomed.com/news/articleView.html?idxno=28087
1 · Reply
Fingerlickengood
Fingerlickengood Oct. 6 at 2:49 PM
$CDXS $BCHMF $ALNY "Efficient Large-scale siRNA Manufacturing" https://www.bachem.com/event/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
0 · Reply
Fingerlickengood
Fingerlickengood Oct. 3 at 8:34 PM
$CDXS $BCHMF 18 new positions in CA for Bachem, if this doesn't signify something BIG I dunno what does! The chemist position is telling speaking directly to an unnamed API! https://www.ziprecruiter.com/co/Bachem/Jobs
0 · Reply
Fingerlickengood
Fingerlickengood Oct. 3 at 3:34 PM
$CDXS $BCHMF NOTE what it says: "Efficient Large-scale SiRNA Manufacturing" Why hasn't Codexis highlighted this webinar? Very suspect to say the least! https://www.bachem.com/event/webinar-efficient-large-scale-sirna-manufacturing-enzymatic-ligation-of-short-rna-fragments/
1 · Reply
Fingerlickengood
Fingerlickengood Oct. 3 at 2:06 PM
$CDXS Have a feeling they are on the presipence of a major announcement with $BCHMF regarding US production of Inclisiran. Mark this post!
0 · Reply
Fingerlickengood
Fingerlickengood Sep. 30 at 4:27 PM
$NVS You gotta wonder, where the specific enzyme was designed/synthesized that $CDXS and $BCHMF are now using in he ECO Lab to produce Inclisiran. This all seems too coincidental. https://www.codexis.com/investors/news-events/press-releases/detail/296/codexis-announces-completion-of-codeevolver-license-technology-transfer-with-global-pharmaceutical-leader
0 · Reply